---
category: listing
circular_id: c7480c4f596effbd
date: '2026-02-26'
description: BSE announces the forthcoming listing of equity shares of Gaudium IVF
  and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF). The exact listing
  date will be communicated via a separate notice.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={AEC56AC0-BC84-42A1-AE5E-78E9664C9338}&noticeno=20260226-7&dt=02/26/2026&icount=7&totcount=28&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Routine new equity listing notice for a healthcare company; specific
  listing date not yet confirmed, limiting immediate actionability, but relevant for
  traders and investors tracking new listings.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260226-7&attachedId=
processing:
  attempts: 1
  content_hash: 2a365fe70300c6db
  processed_at: '2026-02-26T13:19:28.842410'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-26T09:35:40+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={AEC56AC0-BC84-42A1-AE5E-78E9664C9338}&noticeno=20260226-7&dt=02/26/2026&icount=7&totcount=28&flag=0
severity: low
source: bse
stocks:
- GAUDIUMIVF
tags:
- listing
- equity
- new-listing
- ipo
- healthcare
- ivf
- GAUDIUMIVF
title: Listing of Equity Shares of Gaudium IVF and Women Health Limited
---

## Summary

BSE has notified trading members that the equity shares of Gaudium IVF and Women Health Limited will be listed and admitted to dealings on the Exchange. The exact listing date and further security details will be communicated through a separate notice.

## Key Points

- Company: Gaudium IVF and Women Health Limited
- Scrip Code: 544709
- Symbol: GAUDIUMIVF
- ISIN: INE0P8B01020
- Segment: Equity
- Listing date to be announced via a separate notice

## Regulatory Changes

No regulatory changes. This is a standard new listing admission notice under BSE's listing procedures.

## Compliance Requirements

Trading members should note the scrip details and await the follow-up notice from BSE confirming the exact listing date and additional security information before initiating trades.

## Important Dates

- Notice Date: February 26, 2026
- Listing Date: To be announced via a separate notice

## Impact Assessment

This circular has moderate market impact as it signals the imminent listing of a new equity on BSE in the healthcare/fertility services sector. Traders and investors interested in the IVF and women's health space should track the follow-up listing date announcement. No immediate trading action is required until the listing date notice is issued.